NewAmsterdam Pharma (NASDAQ:NAMSW) Trading Up 12.3% – Here’s Why

Shares of NewAmsterdam Pharma (NASDAQ:NAMSW) rose 12.3% during mid-day trading on Wednesday . The company traded as high as $20.07 and last traded at $20.43. Approximately 1,315 shares changed hands during trading, a decline of 27% from the average daily volume of 1,797 shares. The stock had previously closed at $18.20.

NewAmsterdam Pharma Trading Up 10.3%

The firm has a fifty day simple moving average of $21.57 and a 200-day simple moving average of $22.71.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NewAmsterdam Pharma stock. Aristeia Capital L.L.C. bought a new stake in NewAmsterdam Pharma (NASDAQ:NAMSW) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 15,708 shares of the company’s stock, valued at approximately $397,000.

About NewAmsterdam Pharma

NewAmsterdam Pharma, Inc is a clinical-stage biotechnology company focused on the development of orally delivered peptide therapeutics for the treatment of metabolic diseases. Drawing upon proprietary peptide chemistry and formulation technologies, the company aims to transform injectable treatments for conditions such as type 2 diabetes, obesity and related cardiometabolic disorders into convenient, once-daily oral medications. By harnessing advances in peptide stabilization and targeted delivery, NewAmsterdam Pharma seeks to improve patient adherence and expand access to novel therapies.

The company’s lead program is an oral glucagon‐like peptide‐1 (GLP-1) receptor agonist currently in early clinical trials.